NOVEMBERASIA BUSINESS OUTLOOK4 Vol 03 · Issue 10 - 11 · NOVEMBER, 2024 Alok ChaturvediPublisherManaging EditorSudhakar SinghAssociate EditorDarshan KAssistant EditorRoshan AktharEditorial Team Viswanathan ALakshmi PrabhaGM - Media & Graphic Designing VisualizerPrabhu Dutta A.R.N RayEditorial queries editor@asiabusinessoutlook.comSales TeamEmmanuel Das MonicaTo subscribeVisit www.asiabusinessoutlook.com/subscribe/ or send emailto subscription@asiabusinessoutlook.comMagazine Price is $30 per issuePublisher Alok ChaturvediPrinted and Published By Alok Chaturvedi on behalf of Biz Print Media Pvt. Ltd. and Printed at Executive Prints - 113/7, Ground floor, Old madras road, Halasuru, Bangalore 560008 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2024 Biz Print Media Pvt. Ltd. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.Senior Designer Rajesh R BVisualizer Hari Priya VSuanya chakrabortyGM Sales & Marketing N Kumar Circulation Manager P MagendranDriving Pharmaceutical Innovation across Asia The business leaders of Asia's pharmaceutical industry have led it to become a powerhouse of innovation, production and market expansion thanks to their strategic vision and acumen. These leaders, coming from a wide variety of professional backgrounds ­ medicine, biochemistry, engineering, business management ­ have shown great foresight in exploiting the region's huge talent pool and favourable economic conditions. These leaders have been instrumental in advancing the pharmaceutical sector by focusing on three main pillars: research and development, manufacturing scalability and market penetration. Many have also realized the criticality of R&D and strategically invested to build world class facilities to partner with academic institutions. As a result of this emphasis on innovation, generic drug production and biosimilars have been breaking new ground, and more recently, personalized medicine.On the manufacturing side, these leaders have mobilized to create world class production facilities, often using low cost labor and favorable government policies. They have controlled supply chains to optimally do the same, produce competitive priced high quality pharmaceuticals. As it turns out, the right policy has not only satisfied the domestic demand but also made Asian companies the key exporters in the global market. Also, the business leaders have realized and exploited market dynamics and they have been very sharp in terms of market dynamics. Proactive in their expansion in underserved regions and their software service in healthcare in the new generation, they have also considered collaborations in terms of enhancing their product offering. It has not only improved the accessibility of affordable medicines, but also created a huge revenue growth. It is with the view of staying updated with the emerging trends in the region's business landscape that Asia Business Outlook has come up with a special issue containing stories of leaders who have demonstrated their capability through their expertise. To strengthen the business landscape with their tightly-knit and result-oriented approach, they are setting new standards of effectiveness. Your input is valuable to us and we would appreciate your feedbacks and suggestions. Sudhakar SinghManaging Editoreditor@asiabusinessoutlook.com
< Page 3 | Page 5 >